Disease: NADH cytochrome B5 reductase deficiency
- A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis
- A Genetic Map of the Response to DNA Damage in Human Cells
- A microplate reader-based method to quantify NADH-cytochrome b5 reductase activity for diagnosis of recessive congenital methaemoglobinemia
- A NEW CASE OF RECESSIVE CONGENITAL METHEMOGLOBINEMIA LINKED WITH A DIAPHORASE I DEFICIENCY
- A novel G143D mutation in the NADH-cytochrome b5 reductase gene in an Indian patient with type I recessive hereditary methemoglobinemia
- A novel L218P mutation in NADH-cytochrome b5 reductase associated with type I recessive congenital methemoglobinemia
- A novel mutation in type II methemoglobinemia
- A novel nine base deletion mutation in <em>NADH</em>-cytochrome b5 reductase gene in an Indian family with recessive congenital methemoglobinemia-type-II
- A rare cause of mental motor retardation: recessive congenital methemoglobinemia type II
- An Updated View on the Molecular Pathomechanisms of Human Dihydrolipoamide Dehydrogenase Deficiency in Light of Novel Crystallographic Evidence
- Analysis of mutant NADH-cytochrome b5 reductase: apparent "type III" methemoglobinemia can be explained as type I with an unstable reductase
- Application of hepatic cytochrome b<sub>5</sub>/P450 reductase null (HBRN) mice to study the role of cytochrome b<sub>5</sub> in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
- Cellular and Molecular Mechanisms of Recessive Hereditary Methaemoglobinaemia Type II
- Characterization of a novel nicotinamide adenine dinucleotide-cytochrome b5 reductase mutation associated with canine hereditary methemoglobinemia
- Characterization of the amidoxime reducing components ARC1 and ARC2 from Arabidopsis thaliana
- Clinical spectrum and molecular basis of recessive congenital methemoglobinemia in India
- Clinical, metabolic, and genetic characterization of hereditary methemoglobinemia caused by cytochrome b<sub>5</sub> reductase deficiency in cats
- Clinical, metabolic, and molecular genetic characterization of hereditary methemoglobinemia caused by cytochrome b<sub>5</sub> reductase deficiency in 30 dogs
- Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine
- Congenital methaemoglobinaemia in a 61-year-old patient with normal haemoglobin levels
- Congenital methaemoglobinaemia--a rare cause of dyspnoea and cyanosis
- Congenital methaemoglobinaemia: a rare cause of cyanosis in an adult patient
- Congenital methemoglobinaemia due to Hb F-M-Fort Ripley in a preterm newborn
- Congenital methemoglobinemia in a dog with a promoter deletion and a nonsynonymous coding variant in the gene encoding cytochrome b₅
- Congenital Methemoglobinemia Type II-Clinical Improvement with Short-Term Methylene Blue Treatment
- Congenital methemoglobinemia: Rare presentation of cyanosis in newborns
- Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase Gene
- CYB5R3 in type II alveolar epithelial cells protects against lung fibrosis by suppressing TGF-β1 signaling
- Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure
- Cytochrome b5 Reductase 1 Triggers Serial Reactions that Lead to Iron Uptake in Plants
- Cytochrome b5 reductases: Redox regulators of cell homeostasis
- Dissecting the role of multiple reductases in bioactivation and cytotoxicity of the antitumor agent 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1)
- Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase
- Enzymopenic Congenital Methemoglobinemia in Children of the Republic of Sakha (Yakutia)
- Enzymopenic hereditary methemoglobinemia: a clinical/biochemical classification
- Erratum for Clinical, metabolic, and genetic characterization of hereditary methemoglobinemia caused by cytochrome b<sub>5</sub> reductase deficiency in cats
- Erythrocytosis, methemoglobinemia, and the saturation gap
- Establishment of a cellular model with human NADH-cytochrome b5 reductase deficiency via RNA interference
- Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis
- Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling
- Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH-Cytochrome B5 Reductase Gene
- Genetics and biochemistry of NADH-cytochrome b5 reductase deficiency
- HbM methaemoglobinaemia as a rare case of early neonatal benign cyanosis
- HEREDITARY METHEMOGLOBINEMIA DUE TO DIAPHORASE DEFICIENCY IN NAVAJO INDIANS
- Human cytochrome b5 reductase: structure, function, and potential applications
- Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant
- Identification of High-Risk Single Nucleotide Polymorphisms in the Human CYB5R3 Gene Responsible for Recessive Congenital Methemoglobinemia: A Computational Approach
- Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection
- Inborn defects in the antioxidant systems of human red blood cells
- Inflammatory phenotype, clinicopathologic variables, and effects of long-term methylene blue in dogs with hereditary methemoglobinemia caused by cytochrome b5 reductase deficiency
- Iron deficiency aggravates DMNQ-induced cytotoxicity via redox cycling in kidney-derived cells
- Jaundice, Anemia, and Hypoxemia
- Knockdown of several components of cytochrome P450 enzyme systems by RNA interference enhances the susceptibility of Helicoverpa armigera to fenvalerate
- Long-term Treatment with Methylene Blue in a Dog with Hereditary Methemoglobinemia Caused by Cytochrome b5 Reductase Deficiency
- Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice
- Loss of Ncb5or results in impaired fatty acid desaturation, lipoatrophy, and diabetes
- Loss of virulence in NAD(P)H cytochrome b5 oxidoreductase deficient Leishmania major
- Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1
- Membrane-bound CYB5R3 is a common effector of nutritional and oxidative stress response through FOXO3a and Nrf2
- Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells
- Methemoglobin reductase deficiency: novel mutation is associated with a disease phenotype of intermediate severity
- Methemoglobin reduction by NADH-cytochrome b(5) reductase in Propsilocerus akamusi larvae
- Methemoglobin reduction mediated by D-amino acid dehydrogenase in Propsilocerus akamusi (Tokunaga) larvae
- Methemoglobinemia after a mediastinal stab wound
- Methemoglobinemia, Increased Deformability and Reduced Membrane Stability of Red Blood Cells in a Cat with a <em>CYB5R3</em> Splice Defect
- Methemoglobinemia: Living with Dormant Devil
- Molecular basis of two novel mutations found in type I methemoglobinemia
- Mutation update: Variants of the CYB5R3 gene in recessive congenital methemoglobinemia
- NAD(P)H cytochrome b5 oxidoreductase deficiency in Leishmania major results in impaired linoleate synthesis followed by increased oxidative stress and cell death
- NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer
- NADH-cytochrome b5 reductase in a Turkish family with recessive congenital methaemoglobinaemia type I
- NCB5OR Deficiency in the Cerebellum and Midbrain Leads to Dehydration and Alterations in Thirst Response, Fasted Feeding Behavior, and Voluntary Exercise in Mice
- Ncb5or deficiency increases fatty acid catabolism and oxidative stress
- Neurological and Neuroimaging Features of <em>CYB5R3</em>-Related Recessive Hereditary Methemoglobinemia Type II
- Neurometabolic disorder with microcephaly, dystonia, and central cyanosis masquerading as cerebral palsy
- Novel large deletion c.22-1320_633+1224del in the CYB5R3 gene from patients with hereditary methemoglobinemia
- Novel mutation (R192C) in CYB5R3 gene causing NADH-cytochrome b5 reductase deficiency in eight Indian patients associated with autosomal recessive congenital methemoglobinemia type-I
- Oral Methylene Blue Treatment in A Dog with Cytochrome B<sub>5</sub> Reductase Deficiency And 78, XX Testicular Disorder of Sex Development
- Population frequency and age of c.806C > T mutation in CYB5R3 gene as cause of recessive congenital methemoglobinemia in Yakutia
- Prenatal diagnosis of congenital enzymopenic methaemoglobinaemia with mental retardation due to generalized cytochrome b5 reductase deficiency: first report of two cases
- Primaquine-induced severe methemoglobinemia developed during treatment of Plasmodium vivax malarial infection in an Indian family associated with a novel mutation (p.Agr57Trp) in the CYB5R3 gene
- Quinone and nitrofurantoin redox cycling by recombinant cytochrome b5 reductase
- Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency
- Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase
- Recessive congenital methemoglobinemia caused by a rare mechanism: maternal uniparental heterodisomy with segmental isodisomy of a chromosome 22
- Recessive congenital methemoglobinemia due to NADH-cytochrome b5 reductase deficiency associated with recurrent early pregnancy loss (REPL) in an Indian family
- Recessive congenital methemoglobinemia type II: Hypoplastic basal ganglia in two siblings with a novel mutation of the cytochrome b5 reductase gene
- Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum
- Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene
- Recognizing Cyanosis
- Red cell enzymes
- Sperm membrane proteome in wild Japanese macaque (Macaca fuscata) and Sika deer (Cervus nippon)
- Successful management of Methemoglobinemia and G6PD deficiency in a patient posted for surgical excision of branchial cyst
- The CYB5R3<sup>c</sup> <sup>.350C>G</sup> and G6PD A alleles modify severity of anemia in malaria and sickle cell disease
- The cytochrome b<sub>5</sub> CybE is regulated by iron availability and is crucial for azole resistance in A. fumigatus
- The flavoheme reductase Ncb5or protects cells against endoplasmic reticulum stress-induced lipotoxicity
- The importance of plasma membrane coenzyme Q in aging and stress responses
- Three novel mutations in CYB5R3 gene causing NADH-cytochrome b5 reductase enzyme deficiency leads to recessive congenital methaemoglobinemia
- Tight binding of cytochrome b<sub>5</sub> to cytochrome P450 17A1 is a critical feature of stimulation of C21 steroid lyase activity and androgen synthesis
- Vitamin C. Biosynthesis, recycling and degradation in mammals